Minamimoto, R., Fayad, L., Vose, J., Meza, J., Advani, R., Hankins, J., . . . Quon, A. (2021). (18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: A multicenter study. Eur J Nucl Med Mol Imaging.
استشهاد بنمط شيكاغوMinamimoto, Ryogo, et al. "(18)F-Fluorothymidine PET Is an Early and Superior Predictor of Progression-free Survival Following Chemoimmunotherapy of Diffuse Large B Cell Lymphoma: A Multicenter Study." Eur J Nucl Med Mol Imaging 2021.
MLA استشهادMinamimoto, Ryogo, et al. "(18)F-Fluorothymidine PET Is an Early and Superior Predictor of Progression-free Survival Following Chemoimmunotherapy of Diffuse Large B Cell Lymphoma: A Multicenter Study." Eur J Nucl Med Mol Imaging 2021.